Shares of SHF Holdings ticked up to $0.10, an 11.1% gain, after the cannabis-focused financial services company announced a proposed combination with Opifex Media — a deal that would hand 85% ownership to Opifex holders and attempt to reinvent the firm as a diversified Nasdaq-listed holding company. For a stock that has been in freefall, the question isn't whether the pop is real — it's whether any of this will actually close. SHF Holdings Offers 85% of Itself to a Media Startup — Is This a Lifeline or a Surrender?
Shares of SHF Holdings, the cannabis financial-services company trading under the ticker SHFS, edged up to $0.10 after announcing a proposed merger with Opifex Media, a Beverly Hills-based creator-economy firm. With a market capitalization hovering near $136,000, the company is essentially offering its Nasdaq listing to a private company in exchange for survival. Investors should read the fine print before celebrating.
• Current Shareholders Would Be Left With Just 15% of the Combined Company. The term sheet values Opifex at no less than $50 million, with Opifex holders owning 85% and Safe Harbor stakeholders retaining just 15% at closing. For existing SHFS shareholders, this is massive dilution — their slice of the pie shrinks dramatically. Opifex acquires and operates creator-economy businesses across publishing, music, and video, connecting them through a shared data platform and focusing on verified human content. The strategic logic is that a $50 million media business bolted onto a near-zero-value shell could create something worth owning — but only if Opifex's valuation holds up under scrutiny.
• The Deal Is Really About Keeping the Nasdaq Listing Alive. The transaction comes as Safe Harbor works to maintain its Nasdaq listing; on October 20, Nasdaq granted the company an additional 180-day compliance period through April 19, 2027, to meet the exchange's $1 minimum bid price, and the parties intend to close before that deadline. At $0.10 a share, SHFS needs a 10x increase just to stay listed. The company has indicated it may effect a reverse stock split to cure the deficiency if necessary. The Opifex deal is essentially Plan A to avoid that painful step — or delisting altogether.
• The Term Sheet Is Non-Binding, Making This a Speculative Bet. The proposed transaction involves significant dilution, and the dependency on fulfilling multiple conditions — including independent valuations, stockholder approvals, and Nasdaq compliance requirements — introduces substantial uncertainty.
SHFS reported revenue of just $1.9 million in Q2 2026, up a modest 4.84% year-over-year — hardly the profile of a company with negotiating leverage. The wild price swings — from $0.09 to $0.34 and back in a single week — reflect a micro-cap stock driven by headlines, not fundamentals.
• The Creator Economy Is Hot, but the Fit Is Baffling. Goldman Sachs Research estimated the creator economy at roughly $250 billion in 2023, potentially reaching $480 billion by 2027. That's a large market, but cannabis banking and media content have zero operational overlap. CEO Terry Mendez framed it as bringing "a growth-oriented creator-economy platform into our public company." Translation: this is a reverse merger that uses SHFS's listing as a backdoor to public markets for Opifex. Shareholders should ask what, exactly, they're left holding.